ODYSSEY THERAPEUTICS UK LIMITED

Active
Company number 11609778Private limited companyIncorporated 2018

Key figures

£4,040,672-0.1%
Net assets 2025
+36.6%
Average annual growth 2020–2025
02 m4 m6 m202020212022202320242025

ODYSSEY THERAPEUTICS UK LIMITED does not disclose its turnover in its latest accounts; the profit for the year is as stated in the accounts.

Ratios

2025

Sector comparison

SIC 62012

Where the company stands among the 94,838 active companies whose first SIC code is 62012 (Business and domestic software development).

Net assets£4,040,672
Higher than 97% · median £5,624
Total assets£4,142,767
Higher than 95% · median £30,089
Cash£94,806
Higher than 65% · median £31,824
Employees1
Around the median · median 1
Company age8.1 years
Older than 76% · median 2.3 years

Positions are approximate. Figures come from each company's latest accounts; money and employee figures are compared only with companies that filed accounts in pounds for a period ending in the last two and a half years and are not dormant, so those groups are smaller than 94,838. The line on each bar marks the median.

Summary: ODYSSEY THERAPEUTICS UK LIMITED

What kind of company is it?

ODYSSEY THERAPEUTICS UK LIMITED is a private limited company registered with Companies House under company number 11609778. It was incorporated on 8 Oct 2018. Its status is active. The registered office is in Kettering (NN14). Its nature of business (SIC 2007) is business and domestic software development (62012).

How is the company doing financially?

The latest accounts in the database are for 2025 (period ending 31 Dec 2025); the company files small company accounts. Loss for the year was £4,534. Net assets were £4,040,672, down 0.1% on the previous year. Cash at bank and in hand was £94,806. The company had an average of 1 employee. Figures are available for 6 financial years (2020–2025).

How does it compare with similar companies?

Compared with 94,838 active companies whose first SIC code is 62012: By net assets it ranks higher than 97% of them (median £5,624). By total assets it ranks higher than 95% of them (median £30,089). By cash it ranks higher than 65% of them (median £31,824). By number of employees it is around the median of them (1). It is older than 76% of them (median age 2.3 years).

Has it received government grants?

It is recorded as the recipient of 2 central government grants worth £132.3k, from Department for Business, Energy and Industrial Strategy.

What do public registers and reports show?

It appears on the Home Office register of licensed sponsors (Global Business Mobility: Senior or Specialist Worker, Skilled Worker).

Who runs and controls the company?

The company has 1 current director. One person with significant control is registered.

When are its next filings due?

The next accounts are due by 30 Sep 2027. The next confirmation statement is due by 14 Aug 2027.

Filed accounts2020–2025
20212022202320242025
Turnover—2,995,772———
Profit for the year-263,243413,020406,629214,310-4,534
Cash at bank and in hand2,215,409534,737270,785123,78794,806
Total assets3,064,7993,783,9754,092,3274,175,1074,142,767
Total liabilities—————
Net assets / total equity3,011,2473,424,2673,830,8964,045,2064,040,672
Average number of employees1112631

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Government grants

2 grants

ODYSSEY THERAPEUTICS UK LIMITED is recorded as the recipient of 2 central government grants since 2020, together worth £132.3k.

Grants
  1. Quantum technology mapping and map integration for buried assets (QT-MIBA)Department for Business, Energy and Industrial Strategy · £2,729 · UKRI - ISCF - Scheme 22/23
  2. QUANTIFI - QUANTum computIng For heterogeneous catalytIc materials solutions.Department for Business, Energy and Industrial Strategy · £129,618 · ALB - UKRI - Innovate UK grant awards in 20-21

From the Government Grants Register published by the Cabinet Office (financial years 2016/17 onwards, Open Government Licence v3.0). It covers grants from central government departments and their agencies where the register states the recipient's company number and the recipient name matches this company; grants from local authorities, lottery distributors and devolved governments are not included.

Registers and licences

Sponsor licence‡
Licence type and rating
Worker (A rating)
Routes
Global Business Mobility: Senior or Specialist Worker, Skilled Worker

On the Home Office register of licensed sponsors, which lists organisations licensed to sponsor workers from overseas.

Sources: Charity Commission for England and Wales, Care Quality Commission, Home Office and HM Revenue & Customs, under the Open Government Licence v3.0. Entries marked ‡ come from lists that do not state a company number and were linked by an exact match on the registered name.

History

30 events
  1. Miriam CHA resignedDirector
  2. Carl Lee GORDON resignedDirector
  3. Financial year 2025 endedAccounts: net assets £4m, 1 employee
  4. Financial year 2024 endedAccounts: net assets £4m, 3 employees
  5. Charles BAUM resignedDirector
  6. Jill Anne CARROLL resignedDirector
  7. Valerie ODEGARD resignedDirector
  8. Miriam CHA appointedDirector
Earlier events (22)
  1. Financial year 2023 endedAccounts: net assets £3.8m, 6 employees
  2. Financial year 2022 endedAccounts: turnover £3m, net assets £3.4m, 12 employees
  3. Name changed to ODYSSEY THERAPEUTICS UK LIMITEDPreviously RAHKO LIMITED
  4. Financial year 2021 endedAccounts: net assets £3m, 11 employees
  5. Edward Nikolas GRANT resignedDirector
  6. Robert Ian HOROBIN resignedDirector
  7. Leonard Peter WOSSNIG resignedDirector
  8. Gary D. GLICK appointedDirector
  9. Charles BAUM appointedDirector
  10. Jill Anne CARROLL appointedDirector
  11. Carl Lee GORDON appointedDirector
  12. Valerie ODEGARD appointedDirector
  13. Odyssey Therapeutics Inc. registered as a person with significant control
  14. Mr Edward Nikolas Grant ceased to be a person with significant control
  15. Mr Leonard Peter Wossnig ceased to be a person with significant control
  16. Financial year 2020 endedAccounts: net assets £848.9k, 10 employees
  17. Edward Nikolas GRANT appointedDirector
  18. Robert Ian HOROBIN appointedDirector
  19. Leonard Peter WOSSNIG appointedDirector
  20. Mr Edward Nikolas Grant registered as a person with significant control
  21. Mr Leonard Peter Wossnig registered as a person with significant control
  22. Company incorporatedPrivate limited company

Dates as recorded at Companies House: incorporation, name changes, officer appointments and resignations, current and former persons with significant control, and the end of each financial year with figures in the database.